RNA modification systems as therapeutic targets

Davis, F. F. & Allen, F. W. Ribonucleic acids from yeast which contain a fifth nucleotide. J. Biol. Chem. 227, 907–915 (1957).

Article  CAS  PubMed  Google Scholar 

Boccaletto, P. et al. MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res. 50, D231–D235 (2022).

Article  CAS  PubMed  Google Scholar 

Pan, T. Modifications and functional genomics of human transfer RNA. Cell Res. 28, 395–404 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Topisirovic, I., Svitkin, Y. V., Sonenberg, N. & Shatkin, A. J. Cap and cap-binding proteins in the control of gene expression. Wiley Interdiscip. Rev. RNA 2, 277–298 (2011).

Article  CAS  PubMed  Google Scholar 

Cheng, Y. et al. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct. Target. Ther. 4, 62 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Zhong, S. et al. MTA is an Arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factor. Plant Cell 20, 1278–1288 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201–206 (2012).

Article  CAS  PubMed  Google Scholar 

Jia, G. et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885–887 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

He, C. Grand challenge commentary: RNA epigenetics? Nat. Chem. Biol. 6, 863–865 (2010). Together with Jia et al. (2011), this paper pinpoints the biological significance of reversible m6A modification.

Article  CAS  PubMed  Google Scholar 

Zhang, Y., Lu, L. & Li, X. Detection technologies for RNA modifications. Exp. Mol. Med. 54, 1601–1616 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meyer, K. D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 149, 1635–1646 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Geula, S. et al. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. Science 347, 1002–1006 (2015).

Article  CAS  PubMed  Google Scholar 

Mendel, M. et al. Methylation of structured RNA by the m6A writer METTL16 is essential for mouse embryonic development. Mol. Cell 71, 986–1000.e11 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, M. et al. Ythdf2-mediated m6A mRNA clearance modulates neural development in mice. Genome Biol. 19, 69 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Lin, Z. et al. Mettl3-/Mettl14-mediated mRNA N6-methyladenosine modulates murine spermatogenesis. Cell Res. 27, 1216–1230 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fustin, J. M. et al. Two Ck1δ transcripts regulated by m6A methylation code for two antagonistic kinases in the control of the circadian clock. Proc. Natl Acad. Sci. USA 115, 5980–5985 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Liu, N. et al. N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein. Nucleic Acids Res. 45, 6051–6063 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roundtree, I. A. et al. YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. eLife 6, e31311 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Erales, J. et al. Evidence for rRNA 2′-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes. Proc. Natl Acad. Sci. USA 114, 12934–12939 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, F. et al. ALKBH1-mediated tRNA demethylation regulates translation. Cell 167, 816–828.e16 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi, H. et al. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. Cell Res. 27, 315–328 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pandolfini, L. et al. METTL1 promotes let-7 MicroRNA processing via m7G methylation. Mol. Cell 74, 1278–1290.e9 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abakir, A. et al. N6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells. Nat. Genet. 52, 48–55 (2020).

Article  CAS  PubMed  Google Scholar 

Wei, J. & He, C. Chromatin and transcriptional regulation by reversible RNA methylation. Curr. Opin. Cell Biol. 70, 109–115 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, C. et al. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer. Cancer Med. 8, 4766–4781 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, J. et al. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat. Cell Biol. 20, 1074–1083 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia, P. et al. MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Cell Death Dis. 12, 691 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagy, Z. et al. An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability. Nat. Commun. 12, 1881 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raj, N. et al. The Mettl3 epitranscriptomic writer amplifies p53 stress responses. Mol. Cell 82, 2370–2384.e10 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yankova, E. et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 593, 597–601 (2021).

Article  CAS 

Comments (0)

No login
gif